ActiPharma, Inc.
ActiPharma, Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 2 FDA inspections, and 0 compliance actions on record. Its most recent recall (F-0463-2024, Class III) was initiated on September 28, 2023.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 2
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| F-0463-2024 | Class III | ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26) | September 28, 2023 |